The European medicines agency and publication of clinical study reports a challenge for the US FDA

Anna L. Davis, James Miller

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)905-906
Number of pages2
JournalJAMA - Journal of the American Medical Association
Volume317
Issue number9
DOIs
StatePublished - Mar 7 2017

Fingerprint

Drug Approval
Disclosure
Drug Industry
United States Food and Drug Administration
Publications
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The European medicines agency and publication of clinical study reports a challenge for the US FDA. / Davis, Anna L.; Miller, James.

In: JAMA - Journal of the American Medical Association, Vol. 317, No. 9, 07.03.2017, p. 905-906.

Research output: Contribution to journalShort survey

@article{f56995d7ae0b497a8320fc741bced972,
title = "The European medicines agency and publication of clinical study reports a challenge for the US FDA",
author = "Davis, {Anna L.} and James Miller",
year = "2017",
month = "3",
day = "7",
doi = "10.1001/jama.2017.0918",
language = "English (US)",
volume = "317",
pages = "905--906",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - The European medicines agency and publication of clinical study reports a challenge for the US FDA

AU - Davis, Anna L.

AU - Miller, James

PY - 2017/3/7

Y1 - 2017/3/7

UR - http://www.scopus.com/inward/record.url?scp=85015827442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015827442&partnerID=8YFLogxK

U2 - 10.1001/jama.2017.0918

DO - 10.1001/jama.2017.0918

M3 - Short survey

C2 - 28241281

AN - SCOPUS:85015827442

VL - 317

SP - 905

EP - 906

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 9

ER -